Individual Patient Supply (UK MHRA) in Lebanon

How the individual patient supply (uk mhra) pathway operates in Lebanon.

About Individual Patient Supply (UK MHRA)

UK's MHRA individual-patient unlicensed-medicine supply.

How Individual Patient Supply (UK MHRA) works in Lebanon

Lebanon's MoPH has a functional (if under-resourced) named-patient pathway for unregistered drugs.

Patients in Lebanon seeking access under Individual Patient Supply (UK MHRA) typically follow this flow: a licensed physician in Lebanon issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.

Documents required in Lebanon

  • Physician prescription and clinical-justification letter.
  • Patient identification and consent.
  • Country-specific NPP/personal-import form.
  • Hospital or clinic attestation where required.

Typical timeline

End-to-end 2-6 weeks in most tier 3 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.

Start a request

Start a request under Individual Patient Supply (UK MHRA) in Lebanon

AI disclosure & medical review. Content on this page is reviewed by Reserve Meds's AI clinical and regulatory review agents. A US-licensed human pharmacist (sourced through Altima Care, a US-licensed specialty wholesaler) reviews every prescription before dispensing. Regulatory posture is AI-summarized and not legal advice; case-specific questions route to retained outside counsel. Last medically reviewed: .
WhatsApp